Showing results (451-460 of 461) with videos related to
Sort By:
Pageof 47
Current Clinical Pharmacology|January 18, 2014
Medicinal Chemistry of New Compounds to Treat TuberculosisMarina Candido Primi, Natanael Dante Segretti, Elizabeth Igne FerreiraCurrent Clinical Pharmacology|July 17, 2012
Pharmacological Management of PDA: oral versus intravenous medicationsGamze Demirel, Omer Erdeve, Ugur DilmenCurrent Clinical Pharmacology|July 17, 2012
Identification of drug-related problems: a prospective study in two general hospitalsMaher R Khdour, Anan S Jarab, Heba O Adas, et al.Current Clinical Pharmacology|July 17, 2012
The treatment of autoimmune hepatitisStephen Malnick, Gabriel Duek, Ehud Melzer, et al.Current Clinical Pharmacology|October 16, 2012
The concept of titration can be transposed to fluid management. but does is change the volumes? randomised trial on pleth variability index during fast-track colonic surgeryPatrice Forget, Fernande Lois, Alex Kartheuser, et al.Current Clinical Pharmacology|October 16, 2012
The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practicePhilipp Y Maximov, Theresa M Lee, V Craig JordanCurrent Clinical Pharmacology|October 16, 2012
Reported dose as a measure of drug exposure after paracetamol overdose in childrenKatharine J Rutter, Tim Ubhi, Dominic Smith, et al.Current Clinical Pharmacology|August 17, 2016
Humic Acids as Therapeutic Compounds in Lead IntoxicationKlára Krempaská, Ladislav Vaško, Janka VaškováCurrent Clinical Pharmacology|November 16, 2011
Supplementation of glutamine and omega-3 polyunsaturated fatty acids as a novel therapeutic intervention targeting metabolic dysfunction and exercise intolerance in patients with heart failureKhurram Shahzad, Aalap Chokshi, P Christian SchulzeCurrent Clinical Pharmacology|January 18, 2014
Vanadium Complexes with Hydrazone or Thiosemicarbazone Ligands as Potential Anti-Mycobacterium tuberculosis AgentsPaula C de Souza, Pedro I S Maia, Heloisa B de Barros, et al.Pageof 47